Company Filing History:
3 out of 633 
3 out of 1,187 
3 out of 3,684 
Years Active: 2017-2021
Title: Min Lu: Innovator in Antitumor Agents
Introduction
Min Lu is a prominent inventor based in Houston, Texas, known for his significant contributions to the field of medicinal chemistry. He holds three patents that focus on the development of novel antitumor agents, particularly derivatives of uncialamycin. His work has the potential to impact cancer treatment significantly.
Latest Patents
Among his latest patents, Min Lu has developed derivatives of uncialamycin, which include methods of synthesis and their use as antitumor agents. The present disclosure provides new analogs of uncialamycin and novel synthetic pathways for obtaining these compounds. Additionally, it describes methods for using uncialamycin and its analogs. Another aspect of his work involves antibody-drug conjugates that may be utilized to treat cancer or other diseases.
Career Highlights
Min Lu has had a distinguished career, working at notable institutions such as William Marsh Rice University and The Scripps Research Institute. His research has focused on innovative approaches to drug development, particularly in the area of cancer therapeutics.
Collaborations
Throughout his career, Min Lu has collaborated with esteemed colleagues, including Kyriacos Costa Nicolaou and Debashis Mandal. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Min Lu's innovative work in developing antitumor agents showcases his commitment to advancing cancer treatment. His contributions through patents and collaborations highlight the importance of research in the fight against cancer.